Cardinal Health's most recent trend suggests a bullish bias. One trading opportunity on Cardinal Health is a Bull Put Spread using a strike $70.00 short put and a strike $65.00 long put offers a potential 7.53% return on risk over the next 18 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $70.00 by expiration. The full premium credit of $0.35 would be kept by the premium seller. The risk of $4.65 would be incurred if the stock dropped below the $65.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Cardinal Health is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Cardinal Health is bullish.
The RSI indicator is at 76.79 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Cardinal Health
Key Factors to Consider When Choosing an Effective HEOR Analytics Partner
Fri, 30 May 2014 17:34:00 GMT
PR Newswire – In order for medications to become accepted into regular practice, pharmaceutical manufacturers need to present reliable evidence of the value and efficacy of their treatment through Healthcare Economics and Outcomes Research (HEOR), completed by data analytics companies. However, over the years, more data analytics companies have entered the marketplace claiming HEOR expertise, ultimately making the decision-making process for companies seeking a partner more difficult. Cardinal Health Specialty Solutions' BioPharma Analytics team has published a white paper that outlines tips on how to navigate this process. Consider the following questions as your company meets with potential data analytics partners:
Analyst Stocks to Buy for an Aging America
Fri, 30 May 2014 13:05:42 GMT
Exclusive – U.S. companies seek cyber experts for top jobs, board seats
Fri, 30 May 2014 05:16:16 GMT
Nine Companies with the Most Unusual Origins
Tue, 27 May 2014 15:27:07 GMT
New Studies Show Cardinal Health Specialty Solutions' Clinical Pathways Improve Cost Effectiveness and Quality of Treatment of Cancer and Rheumatoid Arthritis
Tue, 27 May 2014 12:30:00 GMT
PR Newswire – DUBLIN, Ohio, May 27, 2014 /PRNewswire/ — A series of new clinical studies found that Cardinal Health Specialty Solutions' Clinical Pathways program sharply reduces the cost of cancer treatment, improves …
Related Posts
Also on Market Tamer…
Follow Us on Facebook